Skip to content

Insurance broker registered with SUSEP 212130733

NeuCorr Seguros

NeuCorr Seguros

Do You Need a Local Insurance Policy for a Clinical Trial in Brazil?

Why sponsors usually need a Brazil-admitted clinical trial insurance policy even with a global master program — and how to arrange it for CEP/CONEP.

Yes — in most cases a clinical trial in Brazil needs a locally admitted policy issued in Brazil, coordinated with your global master policy. That is what Brazil’s ethics system (CEP/CONEP) generally expects as evidence of the participant guarantee, even for sponsors with robust global cover. This guide explains why, and how to set it up without delaying your ethics submission.

The short answer: a local, admitted policy is usually expected

Brazil generally expects the participant’s guarantee to be evidenced by a locally admitted policy — one issued by an insurer authorised to operate in Brazil — even when the sponsor already holds a global master policy abroad. The reasoning is practical: the research-ethics system (CEP/CONEP) and Brazilian regulation operate under local law, in the local currency, and expect documentation that fits the local framework.

This does not make your global program irrelevant. Instead, the local and global policies are coordinated: limits, wordings and triggers are aligned so that participants are protected consistently and there is no gap — or unintended duplication — between the two layers.

Why the local policy matters for ethics approval

Under the framework reinforced by Brazil’s Law 14.874/2024, the sponsor must guarantee assistance and indemnification to participants for study-related harm. When a Research Ethics Committee reviews a protocol, it generally expects to see how that guarantee is secured. A locally admitted policy is the usual, most robust way to document it — which is why arranging it before submission, not after, keeps your timeline on track.

How to set it up

  • Start early. Share the protocol summary, phase, number of participants and sites, the investigational product and the required limits with your local broker before submission.
  • Define the insured parties. Decide who is policyholder, who is insured (sponsor, CRO, site, investigator) and who benefits — this avoids gaps later.
  • Coordinate with the global program. Align the local wording and limits with the master policy so the layers work together.
  • Review conditions and exclusions. Check how the policy responds to study-related harm and what the wording excludes.

For the full picture of what this cover includes, see our pillar guide on clinical trial insurance in Brazil. When you are ready, NeuCorr can arrange the local policy and coordinate it with your global program — talk to our team.

This content is informational and does not replace specific legal, regulatory or insurance advice for your study.

FAQ

Does a global master policy satisfy Brazilian requirements on its own?
Usually not. Even a robust global master policy is generally expected to be supported by a locally admitted policy issued in Brazil, so that the participant guarantee is evidenced within the Brazilian ethics and regulatory system. The two are then coordinated to avoid gaps or overlaps.
When should we arrange the local policy?
Before ethics submission. The CEP/CONEP system generally expects the participant's financial guarantee to be documented as part of the protocol package, so leaving the local policy to the last minute can delay approval and the study start.
What details does the local insurer need?
Typically the protocol summary, study phase, number of participants and sites, the investigational product, the sponsor and CRO details, and the indemnity limits required. Each study is underwritten individually.
Chat with us